TABLE 1.

Demographic and Disease Characteristics of 453 Participants at Start of Rapid IFX Infusions

Characteristic	N = 453 Participants
Age (yrs), median (IQR)	16.0 (13.7–17.9)
Disease duration (yrs), median (IQR)	3.8 (1.9–8.7)
IFX duration (yrs), median (IQR)	1.8 (0.8–3.3)
Rapid IFX dose (mg/kg), median (IQR)	8.0 (6–10)
Male sex (%)	289 (63.8)
IBD type (%)
Crohn’s disease	374 (82.6)
Ulcerative colitis	73 (16.1)
IBD-unclassified	6(1.3)
IFX treatment phase using rapid infusion (%)
Induction	135 (29.8)
Maintenance	318 (70.2)